Published On : 14 Nov 2016
QYResearchReports.com has recently announced adding a new report, presenting industry insights on the global human growth hormone market. The report is titled “Global Human Growth Hormone Market Research Report 2016” and is available for sale on the company website. According to the study, technological advancements and the increasing pool of patients are the two main drivers of the global human growth hormone market.
Besides the increasing compliance of human growth hormones, the market is also gaining from the vast untapped opportunities across the emerging economies such as India and China. The advancements in research and development facilities and the increasing investment in drug development by the leading players in the market are fuelling demand for improved human growth hormones.
Globally, the development of recombinant human growth drugs has increased considerably, alongside which their usage has increased as well. These drugs have also become popular as anti-aging and performance enhancing drugs. The growing awareness about these benefits realized from the consumption of these drugs has been the chief drivers of the global human growth hormone market.
To get sample copy of report visit @ http://www.qyresearchreports.com/sample/sample.php?rep_id=834507&type=E
Human growth hormone helps in stimulating growth in adolescents and children. It is a peptide hormone produced by the pituitary gland. The hormone aids in growth of muscles and bones. Besides stimulating growth, the hormone also participates in the regulation of carbohydrate metabolism, fat metabolism, and protein metabolism. Additionally, human growth hormone drugs have shown positive resulted on a patient’s working capacity, memory, and mental alertness.
Earlier, these drugs were mostly used as replacement therapy in adult and pediatric patients, compliance deficiency in growth hormones. However, the increasing research and development and technological advancements have helped in the development of performance enhancers and anti-aging drugs. The launch of such novel therapeutics holds considerable opportunities for the market’s growth over the course of the forecast period.
The rising incidence of human growth hormone deficiency disease will augment demand for human growth hormone drugs. Furthermore, the growing geriatric population and technological advancements are projected to aid the expansion of the market as well. Additionally, the leading players in the market are likely to invest heavily on the research and development of human growth hormone drugs, thereby leading to the discovery of novel therapeutics. While this holds promise for the market’s growth in the future, stringent regulatory approvals, side effects of drugs, and their high cost may create bottlenecks for the market in the near future.
To study the competition prevailing in the global human growth hormone market, the report profiles companies such as F. Hoffmann-La Roche AG, Pfizer Inc., Eli Lilly and Company, Novo Nordisk A/S, Anhui Anke Biotechnology (Group) Co. Ltd., Merck KGaA, Sandoz, and others.